Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya  John Ojal, PhD, Ulla Griffiths,

Slides:



Advertisements
Similar presentations
The SWPER index for women's empowerment in Africa: development and validation of an index based on survey data  Fernanda Ewerling, MSc, Prof John W Lynch,
Advertisements

Food systems, nutrition, health and the environment
Levels and trends in contraceptive prevalence, unmet need, and demand for family planning for 29 states and union territories in India: a modelling study.
Total and cause-specific mortality before and after the onset of the Greek economic crisis: an interrupted time-series analysis  Ioannis Laliotis, PhD,
The commercial determinants of health
Charity begins at home in global health research funding
Threats to human health by great ocean garbage patches
When less is more: how many doses of PCV are enough?
Prevalence of cerebral palsy in Uganda: a population-based study
Do air quality alerts benefit public health? New evidence from Canada
Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model  Jonathan.
The Lancet Global Health
Gender myths in global health
Nicola Low, Joost H Smid  The Lancet Public Health 
Effective cross-sector collaborations create sustainability
Socioeconomic disparities in first stroke incidence, quality of care, and survival: a nationwide registry-based cohort study of 44 million adults in England 
Kate Raworth  The Lancet Planetary Health 
The effect of explosive remnants of war on global public health: a systematic mixed- studies review using narrative synthesis  Alexandra Frost, MSc, Prof.
Current and future trends in tuberculosis incidence in New York City: a dynamic modelling analysis  Dr Anthony T Fojo, MD, Natalie L Stennis, MPH, Andrew.
Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis  Dr Tinevimbo.
Arnaud Chiolero  The Lancet Public Health 
Jonathan Broad, Matthew D Snape  The Lancet Public Health 
Anthony Rodgers, Alistair Woodward, Boyd Swinburn, William H Dietz 
Effect of air quality alerts on human health: a regression discontinuity analysis in Toronto, Canada  Hong Chen, PhD, Qiongsi Li, MMath, Jay S Kaufman,
Low-level lead exposure and mortality in US adults: a population-based cohort study  Prof Bruce P Lanphear, MD, Stephen Rauch, MPH, Peggy Auinger, MS,
Food systems, nutrition, health and the environment
Changes in chlamydia prevalence and duration of infection estimated from testing and diagnosis rates in England: a model-based analysis using surveillance.
Sherif M Abdalla, Robert Bortolussi, Noni E MacDonald 
Measuring health and economic wellbeing in the Sustainable Development Goals era: development of a poverty-free life expectancy metric and estimates for.
Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis  Cynthia Chen, PhD, Francisco Cervero Liceras, MSc, Stefan.
Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study  Nick.
Democratic reform and health: interpreting causal estimates
Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae.
Risk of poor development in young children in low-income and middle-income countries: an estimation and analysis at the global, regional, and country.
Levels and trends in contraceptive prevalence, unmet need, and demand for family planning for 29 states and union territories in India: a modelling study.
Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry  Hyuna Sung, PhD, Rebecca L Siegel, MPH, Philip S.
Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis  Dr Shevanthi Nayagam,
Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population.
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance.
Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study  Cynthia Schuck-Paim,
Elder abuse prevalence in community settings: a systematic review and meta-analysis  Yongjie Yon, MA, Christopher R Mikton, PhD, Zachary D Gassoumis, PhD,
Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study  Jeanette K Birnbaum, PhD,
Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national.
Anna J Dare, Calvin Ke, Wilson Suraweera, Peter Rodriguez, Prabhat Jha 
The SWPER index for women's empowerment in Africa: development and validation of an index based on survey data  Fernanda Ewerling, MSc, Prof John W Lynch,
Effective interventions for unintentional injuries: a systematic review and mortality impact assessment among the poorest billion  Andres I Vecino-Ortiz,
Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real- world cost analysis and economic evaluation  Prof Anna Vassall,
Tuberculosis control interventions targeted to previously treated people in a high- incidence setting: a modelling study  Florian M Marx, MD, Reza Yaesoubi,
Thank you to our diverse (but not diverse enough) reviewers
Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically- confirmed pneumonia and clinically-defined pneumonia in Kenyan children:
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational.
Matthieu J Guitton  The Lancet Planetary Health 
Contributions of diseases and injuries to widening life expectancy inequalities in England from 2001 to 2016: a population-based analysis of vital registration.
Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial  Thomas Lung, PhD, Guy.
Spatial lifecourse epidemiology
Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review  Alexander K Rowe,
How concentrated are academic publications of countries' progression towards universal health coverage?  Adrian Gheorghe, Kalipso Chalkidou, Anthony Culyer 
Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population.
Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study  Rebecca C Harris, PhD, Tom Sumner, PhD, Gwenan.
Jean H Humphrey, Andrew J Prendergast  The Lancet Global Health 
Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15  Prof Peter Lloyd-Sherlock,
Long-term trends in child maltreatment in England and Wales, 1858–2016: an observational, time-series analysis  Michelle Degli Esposti, BA, David K Humphreys,
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi- eligible countries: a modelling study  Joke Bilcke, PhD, Marina.
Deriving a practical framework for the evaluation of health apps
Trends in, and projections of, indicators of universal health coverage in Bangladesh, 1995–2030: a Bayesian analysis of population-based household data 
Levels and trends in contraceptive prevalence, unmet need, and demand for family planning for 29 states and union territories in India: a modelling study.
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials  Andrew Clark, PhD, Kevin van Zandvoort,
Institutional challenges to achieving health equity in Ecuador
Sickle cell disease: a new era
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a.
Presentation transcript:

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya  John Ojal, PhD, Ulla Griffiths, PhD, Laura L Hammitt, MD, Ifedayo Adetifa, PhD, Donald Akech, BSc, Collins Tabu, PhD, J Anthony G Scott, FRCP, Stefan Flasche, PhD  The Lancet Global Health  Volume 7, Issue 5, Pages e644-e654 (May 2019) DOI: 10.1016/S2214-109X(18)30562-X Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure 1 Model fit to carriage data Recorded (circles, with 95% credible intervals shown by vertical lines) and predicted (horizontal lines, with 95% predictive intervals shown by shaded areas) carriage prevalence of different vaccine serotypes over time. VT=vaccine serotypes. sNVT=strong non-vaccine serotypes. wNVT=weak non-vaccine serotypes. The Lancet Global Health 2019 7, e644-e654DOI: (10.1016/S2214-109X(18)30562-X) Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure 2 Model fit to IPD incidence data Recorded (circles, with 95% credible intervals shown by vertical lines) and predicted (horizontal lines with 95% predictive intervals shown by shaded areas) IPD incidence of vaccine serotypes over time. IPD=invasive pneumococcal disease. VT=vaccine-serotypes. sNVT=strong non-vaccine serotypes. wNVT=weak non-vaccine serotypes. The Lancet Global Health 2019 7, e644-e654DOI: (10.1016/S2214-109X(18)30562-X) Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure 3 IPD incidence, costs, DALYs, and incremental cost-effectiveness ratio if PCV is continued or discontinued in Kenya, 2022–32 Shaded areas are 95% prediction intervals. Vertical dotted lines indicate Gavi transition stages. DALY=disability-adjusted life-year. IPD=invasive pneumococcal disease. PCV=pneumococcal conjugate vaccine. The Lancet Global Health 2019 7, e644-e654DOI: (10.1016/S2214-109X(18)30562-X) Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure 4 Cost-effectiveness acceptability curve Probability of continuing pneumococcal conjugate vaccine being cost-effective against the willingness to pay per DALY averted. DALY=disability adjusted life-year. The Lancet Global Health 2019 7, e644-e654DOI: (10.1016/S2214-109X(18)30562-X) Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions